Showing 101 - 120 results of 268 for search '"hepatitis C virus"', query time: 0.08s Refine Results
  1. 101

    Psychometric Validation of the Hepatitis C Symptom and Impact Questionnaire (HCV-SIQv4) in a Diverse Sample of Adults with Chronic Hepatitis C Virus Infection Treated with an Interferon-free Simeprevir-containing Regimen by Andrew Trigg, Eric Chan, Helen Kitchen, Tom Willgoss, Kai Fai Ho, Renee Pierson, Jane Scott

    Published 2019-02-01
    “…**Background:** Hepatitis C virus (HCV) infection and its treatments are associated with significant symptoms, side effects and impact on patients functioning. …”
    Get full text
    Article
  2. 102
  3. 103
  4. 104

    A 7-Amino Acid Peptide Mimic from Hepatitis C Virus Hypervariable Region 1 Inhibits Mouse Lung Th9 Cell Differentiation by Blocking CD81 Signaling during Allergic Lung Inflammation by Wanzhou Zhao, Conghao Tan, Xi Yu, Ruihe Yu, Qibing Mei, Yun Cheng

    Published 2020-01-01
    “…A 7-amino acid peptide (7P) of the hypervariable region 1 (HVR1) of hepatitis C virus has been identified as an important regulator in the type 2 cytokine (IL-4, IL-5, and IL-13) immune response. …”
    Get full text
    Article
  5. 105
  6. 106
  7. 107

    Marijuana Use in Hepatitis C Infection does not Affect Liver Biopsy Histology or Treatment Outcomes by Theresa Liu, Glen T Howell, Lucy Turner, Kimberley Corace, Gary Garber, Curtis Cooper

    Published 2014-01-01
    “…BACKGROUND: Marijuana smoking is prevalent among hepatitis C virus-infected patients. The literature assessing the influence of marijuana on liver disease progression and hepatitis C virus antiviral treatment outcomes is conflicting.…”
    Get full text
    Article
  8. 108
  9. 109

    Modern modes of chronic hepatitis C treatment by V. T. Ivashkin, M. V. Mayevskaya, M. A. Morozova, Ye. O. Lyusina

    Published 2012-02-01
    “…Moreover, in the close perspective new antiviral agents - protease inhibitors will appear at the market, that allows to increase antiviral treatment efficacy in patients with the 1-st hepatitis C virus genotype.…”
    Get full text
    Article
  10. 110

    Waldenström Macroglobulinemia in Hepatitis C: Case Report and Review of the Current Literature by Ryan Nipp, Aaron Mitchell, Allyson Pishko, Ara Metjian

    Published 2014-01-01
    “…Recent literature has associated hepatitis C virus with the development of non-Hodgkin lymphoma. …”
    Get full text
    Article
  11. 111
  12. 112

    Seroprevalence of Cytomegalovirus, Toxoplasma gondii, Syphilis, and Hepatitis B and C Virus Infections in a Regional Population Seropositive for HIV Infection by Daniel G Johns, M John Gill

    Published 1998-01-01
    “…OBJECTIVE: To determine the prevalence of exposure to cytomegalovirus (CMV), Toxoplasma gondii, syphilis, hepatitis B virus (HBV) and hepatitis C virus (HCV) in a large, well characterized, regional population presenting for human immunodeficency virus (HIV) care.…”
    Get full text
    Article
  13. 113

    Hepatitis C as a Prognostic Indicator among Noncirrhotic Patients Hospitalized with Alcoholic Hepatitis by Paul J Thuluvath, Eric Ahn, Geoffrey C Nguyen

    Published 2013-01-01
    “…OBJECTIVE: A nationwide analysis of alcoholic hepatitis (AH) admissions was conducted to determine the impact of hepatitis C virus (HCV) infection on short-term survival and hospital resource utilization.…”
    Get full text
    Article
  14. 114

    Diagnosis and management of rheumatic manifestations of Hepatitis B, Hepatitis C and immunodeficiency Virus by Arun Ramesh Chogle

    Published 2017-01-01
    “…Hepatitis B, hepatitis C virus and human immunodeficiency virus infections are important causes of virally mediated arthritis. …”
    Get full text
    Article
  15. 115

    A Fractional Order Hepatitis C Mathematical Model with Mittag-Leffler Kernel by Hashim M. Alshehri, Aziz Khan

    Published 2021-01-01
    “…In this paper, a mathematical fractional order Hepatitis C virus (HCV) spread model is presented for an analytical and numerical study. …”
    Get full text
    Article
  16. 116

    Efficacy and Safety of a Novel Pegylated Interferon Alpha-2a in Egyptian Patients with Genotype 4 Chronic Hepatitis C by Alaa Awad Taha, Ahmad El-Ray, Maged El-Ghannam, Bahaa Mounir

    Published 2010-01-01
    “…BACKGROUND: Hepatitis C virus (HCV) genotype 4 is a common infection in Egypt and is the leading cause of liver disease.…”
    Get full text
    Article
  17. 117

    PATHOPHYSIOLOGIC MECHANISMS OF THE INFLUENCE OF TISSUE RESPIRATION ENZYMES ON THE MITOCHONDRIAL FUNCTION IN PATIENTS WITH CHRONIC HEPATITIS C by I.Y. Bagmut, S.M. Gramatiuk

    Published 2018-03-01
    “…The mechanism by which enzymes for energy metabolism suppress the replication of the hepatitis C virus is not yet clear, but it probably includes calcium and dissociation of the mammalian replication complex. …”
    Get full text
    Article
  18. 118
  19. 119

    Quadruple Therapy Offers High SVR Rates in Patients with HCV Genotype 4 with Previous Treatment Failure by Yousry Esam-Eldin Abo-amer, Rehab Badawi, Mohamed El-Abgeegy, Heba Fadl Elsergany, Ahmed Abdelhaleem Mohamed, Sahar Mohamed Mostafa, Hatem Samir Alegaily, Shaimaa Soliman, Sally Elnawasany, Sherief Abd-Elsalam

    Published 2020-01-01
    “…Direct-acting antivirals (DAAs) have made a revolution in hepatitis C virus (HCV) treatment with promising reduction of HCV infection and disease morbidities. …”
    Get full text
    Article
  20. 120

    The Epidemiology of Hepatitis C in a Canadian Indigenous Population by Julia Uhanova, Robert B Tate, Douglas J Tataryn, Gerald Y Minuk

    Published 2013-01-01
    “…BACKGROUND An estimated 1% to 1.9% of North Americans are infected with the hepatitis C virus (HCV). Although Indigenous peoples are considered to bear the highest burden, there are only limited data regarding the demographic features and epidemiology of hepatitis C in this population.…”
    Get full text
    Article